Patents Assigned to Sepsicure, LLC
  • Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
    Patent number: 9023833
    Abstract: The invention relates to a method for treating sepsis in subjects who exhibit serum albumin levels, and one of total cholesterol or HDL levels, above minimum threshold values. The method involves intravenous administration of an emulsion, which contains a phospholipid, a neutral lipid, and a cholate salt.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: May 5, 2015
    Assignee: Sepsicure, LLC
    Inventors: Daniel M. Levine, Thomas S. Parker, Bruce R. Gordon, Stuart D. Saal